Page last updated: 2024-08-24

3-iodobenzylguanidine and Angioblastic Meningioma

3-iodobenzylguanidine has been researched along with Angioblastic Meningioma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Argov, S; Lantsberg, S; Liel, Y; Zirkin, HJ; Zucker, G1
Kinouchi, H; Mizoi, K; Naitoh, Y; Sasajima, T; Tomura, N; Watarai, J1

Other Studies

2 other study(ies) available for 3-iodobenzylguanidine and Angioblastic Meningioma

ArticleYear
Malignant pheochromocytoma simulating meningioma: coexistence of recurrent meningioma and metastatic pheochromocytoma in the base of the skull.
    The Israel Medical Association journal : IMAJ, 2002, Volume: 4, Issue:10

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Diagnosis, Differential; Follow-Up Studies; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pheochromocytoma; Skull Base Neoplasms; Time Factors; Tomography, X-Ray Computed

2002
123I-metaiodobenzylguanidine single-photon emission computerized tomography in brain tumors - a preliminary study.
    Journal of neuro-oncology, 2006, Volume: 77, Issue:2

    Topics: 3-Iodobenzylguanidine; Adult; Aged, 80 and over; Animals; Brain Neoplasms; Child; Child, Preschool; Diagnosis, Differential; Female; Glioma; Humans; Infant; Magnetic Resonance Imaging; Male; Meningioma; Middle Aged; Neoplasms, Germ Cell and Embryonal; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

2006